Immuneering
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $726 | $0 |
Gross Profit | -91 | -175 | 363 | -175 |
EBITDA | -14,665 | -15,392 | -18,465 | -15,177 |
EBIT | -14,757 | -15,484 | -18,558 | -15,273 |
Net Income | -14,433 | -15,046 | -18,051 | -14,597 |
Net Change In Cash | 0 | 0 | 726 | 0 |
Free Cash Flow | -9,448 | -14,090 | -14,519 | -13,477 |
Cash | 26,355 | 35,866 | 36,144 | 45,205 |
Basic Shares | 35,985 | 35,529 | 31,050 | 29,841 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $ | $316 | $2,079 |
Gross Profit | -713 | -764 | 158 | 926 |
EBITDA | -63,686 | -58,060 | -51,467 | -33,726 |
EBIT | -64,071 | -58,412 | -52,264 | -33,886 |
Net Income | -61,037 | -53,471 | -49,281 | -33,535 |
Net Change In Cash | 0 | 316 | 2,079 | |
Cost of Revenue | -2,251 | 37,797 | ||
Free Cash Flow | -55,084 | -49,311 | -44,843 | -30,911 |
Cash | 36,145 | 59,405 | 72,636 | 74,888 |
Basic Shares | 29,981 | 28,416 | 26,386 | 26,320 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.40 |
2025-03-31 | -$0.44 |
2024-12-31 | -$1.07 |
